DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 29.07 0.61%
S&P 500 2,072.83 5.80 0.28%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)

5.44 0.18 (3.42%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVAX $5.44 3.42%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.24
Previous Close $5.26
Daily Range $5.20 - $5.45
52-Week Range $3.34 - $6.95
Market Cap $1.3B
P/E Ratio -17.53
Dividend (Yield) $0.00 (0.0%)
Volume 2,153,613
Average Daily Volume 4,480,816
Current FY EPS -$0.32





Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website:

News & Commentary Rss Feed

Why Novavax, Inc. Stock Skyrocketed 34% in October

Novavax was a top biotech stock in October with a massive 34% gain. See what made Novavax shares shoot to the moon, as well as whether or not its meteoric rise can continue.

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog

Use Options For a Chance To Buy NVAX at a 50% Discount

Today's Dead Cat Bounce Stock: Novavax (NVAX)

Novavax Initiates Phase 2 Clinical Trial Of Quadrivalent Seasonal Influenza VLP

Molecular Biology Meets Finance: MLV's George Zavoico On Ebola's Silver Lining

Today's Dead Cat Bounce Stock Is Novavax (NVAX)

Novavax's (NVAX) CEO Stanley Erck on Q3 2014 Results - Earnings Call Transcript

Morning Market Movers

Benzinga's Top #PreMarket Gainers

See More NVAX News...

NVAX's Top Competitors

NVAX $5.44 (3.42%)
Current stock: NVAX
AMGN $164.72 (1.53%)
Current stock: AMGN
GILD $100.30 (-0.80%)
Current stock: GILD
BIIB $304.92 (-0.16%)
Current stock: BIIB